Efficiency of complex therapy in the treatment of non-alcoholic steatohepatitis and prevention of liver fibrosis
Mikhaĭlichenko, I.S.
Likars'ka Sprava 2010(1-2): 82-86
2010
ISSN/ISBN: 1019-5297 PMID: 20608031 Document Number: 644815
The article describes a positive effect of adjuvant therapy (diet therapy, tsitrarginin, trental) on regression of fatty liver disease, inflammation and prevention of liver fibrosis through influence on the system of L-arginine-NO, exchange of collagen proteins, anti-inflammatory cytokines in patients with steatohepatitis and second type diabetes mellitus.
Document emailed within 1 workday
Related Documents
Kocabay, G.; Telci, A.; Tutuncu, Y.; Tiryaki, B.; Ozel, S.; Cevikbas, U.; Okten, A.; Satman, I. 2011: Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? Bratislavske Lekarske Listy 112(11): 626-629Heebøll, S.; Kazankov, K.; Poulsen, M.K.ær.; Vilstrup, H.; Grønbæk, H. 2012: Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis Ugeskrift for Laeger 174(8): 488-490
Akhmedov, V.A.; P'iannikov, V.V.; Keruchenko, A.L. 2011: Comparison of the immune response in patients with alcoholic liver disease and non-alcoholic steatohepatitis Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 22-25
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Kirsanov, V.S.; Cherednik, N.N. 1987: Complex therapy of alcoholic patients with diseases of the liver and gastrointestinal tract Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(2): 261-265
Liu, X.-d.; Wang, M.; Li, Y.-z. 2010: Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis Zhongguo Zhen Jiu 30(8): 637-641
Yan, S.; Chen, G.-M.; Yu, C.-H.; Zhu, G.-F.; Li, Y.-M.; Zheng, S.-S. 2005: Expression pattern of matrix metalloproteinases-13 in a rat model of alcoholic liver fibrosis Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 569-572
García Monzón, C. 2001: Non-alcoholic steatohepatitis Gastroenterologia y Hepatologia 24(8): 395-402
Pérez, C.; Sauret, J.; Bordes, R.; Cornudelle, R. 1984: Non-alcoholic steatohepatitis associated with malnutrition Medicina Clinica 83(5): 223-224
Méndez-Sánchez, N.; Chávez-Tapia, N.C.; Uribe, M. 2004: Obesity and non-alcoholic steatohepatitis Gaceta Medica de Mexico 140(Suppl 2): S67-S72
Hagymási, K.; Fehér, J.án. 2005: Non-alcoholic steatosis/steatohepatitis Orvosi Hetilap 146(28): 1494-1495
Stel'makh, V.V.; Trashkov, A.P.; Kovalenko, A.L.; Zaplutanov, V.A. 2016: Experimental Assessment of the Specific Efficiency of new Metabolic Drug Runikhol on Models of Non-Alcoholic Fatty Liver Disease Eksperimental'naia i Klinicheskaia Farmakologiia 79(10): 13-17
Chernichenko, N.V.; Sigaev, A.T.; Lovacheva, O.V.; Erokhin, V.V. 2006: Pulmonary scintigraphy in evaluating the efficiency of surfactant therapy in the complex treatment of patients with destructive pulmonary tuberculosis Vestnik Rentgenologii i Radiologii 1: 23-28
Hazuka, V.; Roubal, R. 1987: Polyunsaturated phosphatidylcholine + vitamin B complex in the therapy of alcoholic hepatopathies. A controlled study versus standard therapy La Clinica Terapeutica 123(5): 369-375
Dray, X.; Tainturier, M.H.; De La Lande, P.; Marty, O.; Mallet, L. 2000: Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen Gastroenterologie Clinique et Biologique 24(11): 1122-1123
Itoh, S.; Yougel, T.; Kawagoe, K. 1987: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis American Journal of Gastroenterology 82(7): 650-654
Spahr, L.; Hadengue, A. 2005: Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management Revue Medicale Suisse 1(31): 2032-2034
Alvarez-Martínez, H.éc.E.; Montaño-Estrada, L.F.; Hernández-Cruz, P.; Pérez-Campos, E. 2004: Pathogenic molecular mechanisms in non-alcoholic steatohepatitis Revista de Gastroenterologia de Mexico 69(3): 176-183
Ratziu, V.; Le Calvez, S.; Bonyhay, L.; Taieb, J.; Poynard, T. 2003: Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg? Gastroenterologie Clinique et Biologique 27(10): 869-875